Glenmark Pharmaceuticals posted strong Q3 results with profit and revenue rising over 15% YoY, aided by robust growth in India and North America and sharp operating margin expansion.
Glenmark Pharmaceuticals posted strong Q3 results with profit and revenue rising over 15% YoY, aided by robust growth in India and North America and sharp operating margin expansion.